Keros Therapeutics logo
Keros Therapeutics KROS
$ 17.08 0.95%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Keros Therapeutics Retained Earnings 2011-2024 | KROS

Annual Retained Earnings Keros Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-381 M -228 M -124 M -65 M -19.6 M -7.31 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-7.31 M -381 M -138 M

Quarterly Retained Earnings Keros Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-523 M -470 M -425 M -381 M -341 M -302 M -264 M -228 M -199 M - -148 M -124 M -117 M -96.5 M -80.9 M -65 M -65 M -65 M -65 M -19.6 M -19.6 M -19.6 M -19.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-19.6 M -523 M -184 M